Varmora Granito vs Himalaya Nutravedics vs Anand Seamless IPO: Which Should You Apply To?

Varmora Granito, Himalaya Nutravedics, and Anand Seamless are set to close their IPOs on September 24, 2026. Retail investors must consider various factors, including subscription demand and business fundamentals, to make informed decisions.

Side-by-Side Comparison

Sector Comparison

Varmora Granito operates in the ceramics sector, specializing in tiles, while Himalaya Nutravedics focuses on Ayurvedic and nutraceutical products. Anand Seamless is involved in the iron and steel products sector, producing seamless tubes and pipes.

Issue Size

Varmora Granito has the largest issue size at ₹708.02 crore, followed by Anand Seamless at ₹25.52 crore, and Himalaya Nutravedics at ₹26.5 crore. This significant difference in issue sizes may affect investor interest and allocation strategies.

Subscription Demand

As of September 23, 2026, Anand Seamless shows the strongest subscription demand with a total subscription of 0.74 times, followed by Himalaya Nutravedics at 0.4 times and Varmora Granito at 0.27 times. Notably, Anand Seamless has higher demand from HNI investors, indicating a strong interest in its offering.

Business Fundamentals

Varmora Granito has a robust distribution network with over 2,000 multi-brand outlets and exports to over 100 countries, showcasing its strong market presence. Himalaya Nutravedics benefits from integrated manufacturing capabilities and a broad therapeutic coverage in the wellness sector, which may appeal to health-conscious consumers. Anand Seamless emphasizes quality with international accreditations and a diversified product range, catering to various industries, including oil and gas.

Strengths and Weaknesses

While Varmora Granito lacks specified strengths and weaknesses, Himalaya Nutravedics highlights its strong relationships with suppliers and doctors as a competitive advantage. Anand Seamless emphasizes its effective quality control and experienced team as key strengths, although no weaknesses are mentioned for any of the companies.

Disclaimer: This is an objective comparison of publicly available IPO data, not investment advice or a personal recommendation to apply for any specific IPO. GMP is unofficial and unregulated. TopFund is not a SEBI-registered investment adviser — please do your own research or consult a qualified adviser before applying.